TLR4 and prostate carcinoma: Recently, some studies showed that the PRDX1 was overexpressed in various human tumors such as breast, lung, urinary, and hepatocellular carcinoma, and its interaction with toll-like receptor 4 (TLR4) stimulates tumor angiogenesis in prostatic carcinoma [30].